About
Dr. Daniel L. Kaufman is a Professor in the Department of Molecular and Medical Pharmacology at the David Geffen School of Medicine, UCLA. His research focuses on immunotherapeutics for immune-mediated disorders, particularly type 1 diabetes, multiple sclerosis, and neuroinflammation associated with long COVID. He has developed GABA receptor agonists as anti-inflammatory therapeutics and demonstrated their efficacy in preclinical models of autoimmune diseases and SARS-CoV-2 infection.
- Developed clinical-grade therapies for type 1 diabetes
- Discovered GABA's role in inhibiting neuroinflammation
- Repurposed GABA agonists for COVID-19 immune dysregulation
His recent work explores GABA's impact on glioblastoma immune evasion and long-COVID neuroinflammation. Key collaborators include researchers in pharmacology and neuroimmunology. Over 30 years, he has secured continuous NIH funding for studies on beta-cell autoimmunity and GABA signaling in inflammation.
Find Daniel L Kaufman elsewhere
Related Searches
You Might Also Like
- DDaniel L. KaufmanUniversity of California, Los Angeles · Professor
Daniel KaufmanUniversity of California, Los Angeles · Professor
Jide TianUniversity of California, Los Angeles · Adjunct Professor- YYi (Jody) Ye-MillerAlbert Einstein College of Medicine · Researcher
Alessandro DidonnaEast Carolina University · Assistant Professor
Mastura MonifMonash University · Associate Professor